Eris Lifesciences Ltd. - Research Center
540596 ERIS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | 436.91 | 458.54 | 388.89 | 323.59 | 311.78 |
| Net cashflow-operating activity | 322.33 | 369.41 | 395.41 | 265.19 | 216.31 |
| Net cash used in investing activity | -513.30 | -267.64 | -347.86 | 126.80 | 2.08 |
| Netcash used in fin. activity | 193.75 | -88.42 | -81.13 | -333.52 | -220.74 |
| Net inc/dec in cash and equivlnt | 2.78 | 13.36 | -33.58 | 58.47 | -2.34 |
| Cash and equivalnt begin of year | 44.70 | 31.35 | 64.93 | 6.46 | 8.81 |
| Cash and equivalnt end of year | 47.48 | 44.70 | 31.35 | 64.93 | 6.46 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis